Search research articles
Contact Us
Filters
Showing results (351-360 of 775) with videos related to
Page
of 78
Sort By:
The Medical Journal of Australia
|
March 16, 2011
A web-based normative data tool for assessing cognitive performance in healthy older Australians
Simon J McBride, Cassandra E I Szoeke, Norm M Good, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
July 26, 2023
A universal neocortical mask for Centiloid quantification
Pierrick Bourgeat, Vincent Doré, Christopher C Rowe, et al.
Neuroreport
|
May 9, 2002
Alternative transcripts of presenilin-1 associated with frontotemporal dementia
Geneviève Evin, Margaret J Smith, Angela Tziotis, et al.
Journal of Clinical and Experimental Neuropsychology
|
January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Yen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Scientific Reports
|
September 30, 2025
Proteomic analysis of brain and spinal cord tissue reveals distinct immune and mitochondrial processes between human and mouse ALS models
Alanna G Spiteri, Joel R Steele, Han-Chung Lee, et al.
JAMA Neurology
|
May 29, 2013
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease
Vincent Doré, Victor L Villemagne, Pierrick Bourgeat, et al.
Proteins
|
June 5, 2013
Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study
Chi L L Pham, Nigel Kirby, Kathleen Wood, et al.
The Journal of Biological Chemistry
|
August 23, 2002
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2)
Carlos Opazo, Xudong Huang, Robert A Cherny, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 17, 2017
Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort
Veer Bala Gupta, Eugene Hone, Steve Pedrini, et al.
Biochemistry
|
February 24, 2006
Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11
Olav M Andersen, Vanessa Schmidt, Robert Spoelgen, et al.
Page
of 78
Search research articles
Search
Showing results (351-360 of 775) with videos related to
Sort By:
Page
of 78
The Medical Journal of Australia
|
March 16, 2011
A web-based normative data tool for assessing cognitive performance in healthy older Australians
Simon J McBride, Cassandra E I Szoeke, Norm M Good, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
July 26, 2023
A universal neocortical mask for Centiloid quantification
Pierrick Bourgeat, Vincent Doré, Christopher C Rowe, et al.
Neuroreport
|
May 9, 2002
Alternative transcripts of presenilin-1 associated with frontotemporal dementia
Geneviève Evin, Margaret J Smith, Angela Tziotis, et al.
Journal of Clinical and Experimental Neuropsychology
|
January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Yen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Scientific Reports
|
September 30, 2025
Proteomic analysis of brain and spinal cord tissue reveals distinct immune and mitochondrial processes between human and mouse ALS models
Alanna G Spiteri, Joel R Steele, Han-Chung Lee, et al.
JAMA Neurology
|
May 29, 2013
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease
Vincent Doré, Victor L Villemagne, Pierrick Bourgeat, et al.
Proteins
|
June 5, 2013
Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study
Chi L L Pham, Nigel Kirby, Kathleen Wood, et al.
The Journal of Biological Chemistry
|
August 23, 2002
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2)
Carlos Opazo, Xudong Huang, Robert A Cherny, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 17, 2017
Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort
Veer Bala Gupta, Eugene Hone, Steve Pedrini, et al.
Biochemistry
|
February 24, 2006
Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11
Olav M Andersen, Vanessa Schmidt, Robert Spoelgen, et al.
Page
of 78